Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26712084

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Apr 9
First author
Herbst RS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Apr 9;387(10027):1488-1490. doi: 10.1016/S0140-6736(15)01308-2.
    note
    Source null
    related pmid
    26712085
    relationship
    Comment in
  2. citation
    J Thorac Dis. 2017 Nov;9(11):4187-4190. doi: 10.21037/jtd.2017.10.135.
    note
    Source null
    related pmid
    29268467
    relationship
    Comment in
  3. citation
    J Thorac Dis. 2017 Dec;9(12):4821-4824. doi: 10.21037/jtd.2017.10.152.
    note
    Source null
    related pmid
    29312666
    relationship
    Comment in

Authors and identifiers

  1. name
    Herbst RS
    type
    Author
  2. name
    Baas P
    type
    Author
  3. name
    Kim DW
    type
    Author
  4. name
    Felip E
    type
    Author
  5. name
    Pérez-Gracia JL
    type
    Author
  6. name
    Han JY
    type
    Author
  7. name
    Molina J
    type
    Author
  8. name
    Kim JH
    type
    Author
  9. name
    Arvis CD
    type
    Author
  10. name
    Ahn MJ
    type
    Author
  11. name
    Majem M
    type
    Author
  12. name
    Fidler MJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Herbst RS
    type
    Author
  2. name
    Baas P
    type
    Author
  3. name
    Kim DW
    type
    Author
  4. name
    Felip E
    type
    Author
  5. name
    Pérez-Gracia JL
    type
    Author
  6. name
    Han JY
    type
    Author
  7. name
    Molina J
    type
    Author
  8. name
    Kim JH
    type
    Author
  9. name
    Arvis CD
    type
    Author
  10. name
    Ahn MJ
    type
    Author
  11. name
    Majem M
    type
    Author
  12. name
    Fidler MJ
    type
    Author
bibliography ids
  1. nci-bib-75965dee18782ce8b4ad0eaf
book metadata
content sha256
750f01faed68099912cc7496ec680d40156847b826f12c2d1585d0cb1ccfa726
document type
citation
dois
  1. 10.1016/S0140-6736(15)01281-7
electronic publication date
display
2015 Dec 19
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26712084
immutable id
pubmed:26712084@750f01faed68099912cc7496ec680d40156847b826f12c2d1585d0cb1ccfa726
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10027
name
Lancet (London, England)
nlm unique id
2985213R
pages
1540-1550
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Apr 9;387(10027):1488-1490. doi: 10.1016/S0140-6736(15)01308-2.
    note
    Source null
    related pmid
    26712085
    relationship
    Comment in
  2. citation
    J Thorac Dis. 2017 Nov;9(11):4187-4190. doi: 10.21037/jtd.2017.10.135.
    note
    Source null
    related pmid
    29268467
    relationship
    Comment in
  3. citation
    J Thorac Dis. 2017 Dec;9(12):4821-4824. doi: 10.21037/jtd.2017.10.152.
    note
    Source null
    related pmid
    29312666
    relationship
    Comment in
outcomes validated
false
pmid
26712084
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
398419fc84fd77586db7546547f92939b111569dbc4ed4fe9437535594fec416
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Apr 9
precision
day
year
2016
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26712084/
title
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Preserved source evidence · Not medical advice